A double-blind, randomized, placebo-controlled, parallel-group study of THC/CBD oromucosal spray in combination with the existing treatment regimen, in the relief of central neuropathic pain in patients with multiple sclerosis
May 8, 2017
Journal of Neurology, 2013: THC fares well vs. Placebo in treatment of pain.
There has never been a more important time to support this vital work. We are fighting for the rights of all Utahns: for dignity, for respect, and to improve our quality of life.
